In short

J0135 is the HCPCS Level II code for injection, adalimumab, 20 mg. One billing unit is 20 mg.

Code

Med-Code curated
HCPCS codeJ0135
Billing unit20 mg
Descriptor
Injection, adalimumab, 20 mg
Code set
HCPCS Level II, maintained by CMS

Units and claim line

Units = dose given ÷ 20 mg. For example, 2000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Enter the dose given to build the claim line.

Drugs mapped to J0135

FDA-listed products billed under J0135

Finished products in the FDA NDC Directory whose brand or single active ingredient, and route, match this code’s entry.

NDC products matching J0135
ProductStrengthForm · routeLabelerProduct NDC
Adalimumabadalimumab-adazAdalimumab 80 mg/.8mLInjection, SolutionSubcutaneousSandoz Inc61314-325
Adalimumabadalimumab-adazAdalimumab 40 mg/.4mLInjection, SolutionSubcutaneousSandoz Inc61314-327
Adalimumabadalimumab-adazAdalimumab 20 mg/.2mLInjection, SolutionSubcutaneousSandoz Inc61314-332
Adalimumabadalimumab-adazAdalimumab 10 mg/.1mLInjection, SolutionSubcutaneousSandoz Inc61314-391
Adalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousCordavis Limited83457-186
Adalimumab-bwwdAdalimumab 40 mg/.4mLSolutionSubcutaneousCordavis Limited83457-187
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousAmgen, Inc55513-399
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-400
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-410
Amjevitaadalimumab-attoAdalimumab 20 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-411
Amjevitaadalimumab-attoAdalimumab 10 mg/.2mLInjectionSubcutaneousAmgen, Inc55513-413
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-479
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-480
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen, Inc55513-481
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen, Inc55513-482
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousAmgen USA Inc.72511-399
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneousAmgen USA Inc.72511-400
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen USA Inc.72511-479
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousAmgen USA Inc.72511-481
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousAmgen USA Inc.72511-482
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneousNuvaila Limited84612-399
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousNuvaila Limited84612-479
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneousNuvaila Limited84612-481
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneousNuvaila Limited84612-482
Hadlimaadalimumab-bwwdAdalimumab 40 mg/.8mLSolutionSubcutaneousA-S Medication Solutions50090-6705

All NDCs for these drugs

J0135: common questions

Is J0135 a CPT code?
No. J0135 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What is one billing unit of J0135?
One unit of J0135 is 20 mg, as stated in the code's descriptor. Units to report = dose given ÷ 20 mg. J-code billing units.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in